PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NRO | Ann: NRMBS Trust 2018-1 (NRO) - (February) Investor Report | 25/03/24 | 0 | 75 | |||
|
|||||||
NRO | Ann: NRMBS Trust 2018-1 2023 Financial Report | 07/02/24 | 0 | 99 | |||
|
|||||||
NRO | Ann: NRMBS Trust 2018-1 Monthly Investor Report | 17/02/23 | 0 | 116 | |||
|
|||||||
NRO | Ann: Financial Report - 30 September 2022 | 09/02/23 | 0 | 124 | |||
|
|||||||
NRO | Ann: NRMBS Trust 2018-1 Monthly Investor Report | 19/09/22 | 0 | 128 | |||
|
|||||||
NRO | Ann: Financial Report for year ended 30 September 2021 | 07/02/22 | 0 | 224 | |||
|
|||||||
NRO | Ann: NRMBS Trust 2018-1 Monthly Investor Report | 18/11/21 | 0 | 191 | |||
|
|||||||
NRO | Ann: NRMBS Trust 2018-1 Monthly Investor Report | 19/10/21 | 0 | 205 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||